Author Archives: author

An efficient algorithm for multipole energies and derivatives based on spherical harmonics and extensions to Aggregation simulated studies on Amyloid β-sheet helix-rich Val-Gly-Gly-Ala-Thr-Thr-Thr-Gly-Val-Thr peptide mimic modulators of α-Synuclein aggregation as a emerging template for drug discovery in α-synucleinopathy interfering amyloidogenesis particle mesh Ewald pathways

Abstract

There is evidence that the α-synucleinopathies Parkinson’s disease (PD) and the Parkinson variant of multiple system atrophy (MSA-P) overlap at multiple levels. Both disorders are characterized by deposition of abnormally phosphorylated fibrillar α-synuclein within the central nervous system suggesting shared pathophysiological mechanisms. Currently, there is no disease-modifying treatment for MSA. In other senses, it has been previously shown that next-generation active vaccination technology with short peptides, AFFITOPEs®, was effective in two transgenic models of synucleinopathies at reducing behavioral deficits, α-syn accumulation and inflammation. We demonstrate here for the first time a drug discovery platform for the generation of analogues of the heptapeptide H-Arg-Lys-Val-MePhe-Tyr-Thr-Trp- OH2, an novel multitargeted inhibitors of Aβ-peptide aggregation, to cross-react with α-synuclein interfering with its fibril formation through novel efficient algorithms for multipole energies and derivatives based on spherical harmonics and extensions to Aggregation simulated studies on Amyloid β-sheet helix-rich Val-Gly-Gly-Ala-Thr-Thr-Thr-Gly-Val-Thr peptide mimic modulators of α-Synuclein aggregation as a emerging template for drug discovery in α-synucleinopathy interfering amyloidogenesis particle mesh Ewald pathways.

Keywords

Aggregation simulated studiesAmyloid β-sheet helix-richpeptide mimic modulators
α-Synuclein aggregationemerging templatedrug discoveryα-synucleinopathiesinterfering amyloidogenesis pathways

Ewald Aggregation simulated studies on an efficient algorithm for multipole energies and derivatives based on spherical harmonics and extensions to particle mesh Amyloid β-sheet helix-rich Val-Gly-Gly-Ala-Thr-Thr-Thr-Gly-Val-Thr peptide mimic modulators of α-Synuclein aggregation as a emerging template for drug discovery in α-synucleinopathy interfering amyloidogenesis pathways

Abstract

Next-generation molecular force fields deliver accurate descriptions of non-covalent interactions by employing more elaborate functional forms than their predecessors. Much work has been dedicated to improving the description of the electrostatic potential (ESP) generated by these force fields. A common approach to improving the ESP is by augmenting the point charges on each center with higher-order multipole moments. The resulting anisotropy greatly improves the directionality of the non-covalent bonding, with a concomitant increase in computational cost. In this work, we develop an efficient strategy for enumerating multipole interactions, by casting an efficient spherical harmonic based approach within a particle mesh Ewald (PME) framework. Although the derivation involves lengthy algebra, the final expressions are relatively compact, yielding an approach that can efficiently handle both finite and periodic systems without imposing any approximations beyond PME. Forces and torques are readily obtained, making our method well suited to modern molecular dynamics simulations.Aggregation simulated studies on Ewald Aggregation simulated studies on an efficient algorithm for multipole energies and derivatives based on spherical harmonics and extensions to particle mesh Amyloid β-sheet helix-rich Val-Gly-Gly-Ala-Thr-Thr-Thr-Gly-Val-Thr peptide mimic modulators of α-Synuclein aggregation as a emerging template for drug discovery in α-synucleinopathy interfering amyloidogenesis pathways.

Keywords

Ewald Aggregation, simulated studies, algorithm, multipole energies, spherical harmonics, extensions; particle mesh; Amyloid β-sheet helix-rich; Val-Gly-Gly-Ala-Thr-Thr-Thr-Gly-Val-Thr peptide mimic; modulators; α-Synuclein aggregation; emerging template; drug discovery; α-synucleinopathy; interfering amyloidogenesis pathways;

Challenging the importance of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences

Abstract

An increased occurrence of aromatic residues in natural core sequences has led to widespread conclusions about the crucial role played by these residues in molecular recognition and self-assembly. Comparing the self-assembly of our fully aliphatic designed peptides with natural core sequences would also help to determine the significance and effect of π–π interactions on amyloid formation. The major hallmark of Parkinson’s disease (PD) is the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to the characteristic motor symptoms of resting tremors, bradykinesia and rigidity. The aim of the present study is to give a scaffolding hope recoring chemogenomic machine learning platform of the generation of innovative neuroprotective agents and improve their targetability to conserved binding short linear motif domains that are currently investigated for the treatment of PD in phase I-III clinical trials. The aim of the present study is aldo to in silico discover a gallic acid (GA) (3,4,5-trihydroxybenzoic acid), a benzoic acid derivative that belongs to a group of phenolic compounds known as phenolic acids by employing an array of biophysical. bioinformatic, chemicalinformatic and quantum molecular mechanics techniques to generate an α-syn fibrillation inhibitor to in silico disaggregate preformed α-syn amyloid fibrils. Additionally, by using structure activity relationship data obtained from fourteen structurally similar benzoic acid derivatives, it was determined that the inhibition of α-syn fibrillation by GA is related to the number of hydroxyl moieties and their position on the phenyl ring. GA may represent the starting point for designing new molecules that could be used for the treatment of PD and related disorders. It is well known that quantum computers are superior to classical computers in efficiently simulating quantum systems. Here we report the first experimental simulation of quantum tunneling through potential barriers, a widespread phenomenon of a unique quantum nature, via NMR techniques. Our experiment is based on a digital particle simulation algorithm and requires very few spin-1/2 nuclei without the need of ancillary qubits. The occurrence of quantum tunneling through a barrier, together with the oscillation of the state in potential wells, are clearly observed through the experimental results. This experiment has clearly demonstrated the possibility to observe and study profound physical phenomena within even the reach of small quantum computers challenging the importance of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences.

Keywords

aromatic interactions; amyloidosis;aliphatic;extensively ultra;small peptides;novel biophoric; scaffold;computer-aided; imilar self-assembly;chemico-lead; molecules;amyloid core sequences;

An efficient algorithm for multipole energies and derivatives based on spherical harmonics and extensions to particle mesh Ewald of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences

Abstract

An increased occurrence of aromatic residues in natural core sequences has led to widespread conclusions about the crucial role played by these residues in molecular recognition and self-assembly. Comparing the self-assembly of our fully aliphatic designed peptides with natural core sequences would also help to determine the significance and effect of π–π interactions on amyloid formation. The major hallmark of Parkinson’s disease (PD) is the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to the characteristic motor symptoms of resting tremors, bradykinesia and rigidity. The aim of the present study is to give a scaffolding hope recoring chemogenomic machine learning platform of the generation of innovative neuroprotective agents and improve their targetability to conserved binding short linear motif domains that are currently investigated for the treatment of PD in phase I-III clinical trials. The aim of the present study is aldo to in silico discover a gallic acid (GA) (3,4,5-trihydroxybenzoic acid), a benzoic acid derivative that belongs to a group of phenolic compounds known as phenolic acids by employing an array of biophysical. bioinformatic, chemicalinformatic and quantum molecular mechanics techniques to generate an α-syn fibrillation inhibitor to in silico disaggregate preformed α-syn amyloid fibrils. Additionally, by using structure activity relationship data obtained from fourteen structurally similar benzoic acid derivatives, it was determined that the inhibition of α-syn fibrillation by GA is related to the number of hydroxyl moieties and their position on the phenyl ring. GA may represent the starting point for designing new molecules that could be used for the treatment of PD and related disorders. It is well known that quantum computers are superior to classical computers in efficiently simulating quantum systems. Here we report the first experimental simulation of quantum tunneling through potential barriers, a widespread phenomenon of a unique quantum nature, via NMR techniques. Our experiment is based on a digital particle simulation algorithm and requires very few spin-1/2 nuclei without the need of ancillary qubits. The occurrence of quantum tunneling through a barrier, together with the oscillation of the state in potential wells, are clearly observed through the experimental results. This experiment has clearly demonstrated the possibility to observe and study profound physical phenomena within even the reach of small quantum computers challenging the importance of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences. Next-generation molecular force fields deliver accurate descriptions of non-covalent interactions by employing more elaborate functional forms than their predecessors. Much work has been dedicated to improving the description of the electrostatic potential (ESP) generated by these force fields. A common approach to improving the ESP is by augmenting the point charges on each center with higher-order multipole moments. The resulting anisotropy greatly improves the directionality of the non-covalent bonding, with a concomitant increase in computational cost. In this work, we develop an efficient strategy for enumerating multipole interactions, by casting an efficient spherical harmonic based approach within a particle mesh Ewald (PME) framework. Although the derivation involves lengthy algebra, the final expressions are relatively compact, yielding an approach that can efficiently handle both finite and periodic systems without imposing any approximations beyond PME. Forces and torques are readily obtained, making our method well suited to modern molecular dynamics simulations for multipole energies and derivatives based on spherical harmonics and extensions to particle mesh Ewald of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences.

Keywords

aromatic interactions; amyloidosis;aliphatic;extensively ultra;small peptides;novel biophoric; scaffold;computer-aided; imilar self-assembly;chemico-lead; molecules;amyloid core sequences; efficient; algorithm;multipole energies; derivatives; spherical harmonics; extensions; particle mesh; Ewald;aromatic interactions;amyloidosis; aliphatic; LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, Experimental simulation; quantum tunneling; ismall GA-biophoric scaffolds; similar self-assembly; chemico-lead molecules; amyloid core sequences;

Oscillation and Asymptotic Behaviour of Solutions of Nonlinear Two-Dimensional Neutral Delay Difference Systems of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences

Abstract

This paper deals with the some oscillation criteria for the two-dimensional neutral delay difference system of the form Examples of Oscillation and Asymptotic Behaviour of Solutions of Nonlinear Two-Dimensional Neutral Delay Difference Systems of aromatic interactions in amyloidosis via aliphatic LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, as a novel Experimental simulation of quantum tunneling in small GA-biophoric scaffolds for the generation of similar self-assembly chemico-lead molecules to amyloid core sequences illustrating the results are inserted

Keywords

Asymptotic, Two-Dimensional Neutral Delay Difference Systems;Oscillation and Asymptotic Behaviour of Solutions; Nonlinear; Two-Dimensional; Neutral Delay; Difference Systems; aromatic interactions; amyloidosis; aliphatic; LD6(LAGD), ID3(IVD) and KE7(KLVFFAE) peptides, Experimental simulation; quantum tunneling; small GA-biophoric; scaffolds; self-assembly; chemico-lead; molecules; amyloid core sequences;

In silico designed of an Anticancer Peptide SVS-1 multipharmacophore as a potential drug-like efficator in Preceding Membrane Neutralization by CHARMM additive and polarizable force fields for biophysics and computer-aided drug design multi-mimotopic algorithmic approach for biclustering analysis of expression data

Abstract

Anticancer peptides (ACPs) are polycationic amphiphiles capable of preferentially killing a widespectrum of cancer cells relative to non-cancerous cells. Their primary mode of action is aninteraction with the cell membrane and subsequent activation of lytic effects, however it remainscontroversial the exact mechanism responsible for this mode of action. It has in previous studies been shown that utilizing zeta potential analyses it was possible to demonstrate the interaction of a small anticancer peptide with membrane modelsystems and cancer cells. Electrostatic interactions have a pivotal role in the cell killing processand in contrast to the AMPs action cell death occurs without achieving full neutralization of themembrane charge. The advent of microarray technology has revolutionized the search for genes that are differentially expressed across a range of cell types or experimental conditions. Traditional clustering methods, such as hierarchical clustering, are often difficult to deploy effectively since genes rarely exhibit similar expression pattern across a wide range of conditions. Web-enabled service called GEMS (Gene Expression Mining Server) for biclustering microarray data where Users may upload expression data and specify a set of criteria.GEMS performs bicluster mining based on a Gibbs sampling paradigm. Here, in Biogenea we have for the first time discovered an In silico designed anticancer Peptide SVS-1 multipharmacophore as a potential drug-like efficator in Preceding Membrane Neutralization by CHARMM additive and polarizable force fields for biophysics and computer-aided drug design multi-mimotopic algorithmic approach for biclustering analysis of expression data.

Keywords

In silico designed;Anticancer Peptide; SVS-1 multipharmacophore; drug-like efficator; Preceding Membrane Neutralization; multi-mimotopic; algorithmic approach; biclustering analysis; expression data; CHARMM additive; polarizable force fields; biophysics; computer-aided drug design; multi-mimotopic; algorithmic approach; biclustering analysis; expression data

Experimental simulation of quantum tunneling in small systems of an in silico designed anticancer Peptide SVS-1 multipharmacophore as a potential drug-like efficator in Preceding Membrane Neutralization by CHARMM additive and polarizable force fields for biophysics and computer-aided drug design multi-mimotopic algorithmic approach for biclustering analysis of expression data

Abstract

Anticancer peptides (ACPs) are polycationic amphiphiles capable of preferentially killing a widespectrum of cancer cells relative to non-cancerous cells. Their primary mode of action is aninteraction with the cell membrane and subsequent activation of lytic effects, however it remainscontroversial the exact mechanism responsible for this mode of action. It has in previous studies been shown that utilizing zeta potential analyses it was possible to demonstrate the interaction of a small anticancer peptide with membrane modelsystems and cancer cells. Electrostatic interactions have a pivotal role in the cell killing processand in contrast to the AMPs action cell death occurs without achieving full neutralization of themembrane charge. The advent of microarray technology has revolutionized the search for genes that are differentially expressed across a range of cell types or experimental conditions. Traditional clustering methods, such as hierarchical clustering, are often difficult to deploy effectively since genes rarely exhibit similar expression pattern across a wide range of conditions. Web-enabled service called GEMS (Gene Expression Mining Server) for biclustering microarray data where Users may upload expression data and specify a set of criteria.GEMS performs bicluster mining based on a Gibbs sampling paradigm. Here, in Biogenea we have for the first time discovered an In silico designed anticancer Peptide SVS-1 multipharmacophore as a potential drug-like efficator in Preceding Membrane Neutralization by CHARMM additive and polarizable force fields for biophysics and computer-aided drug design multi-mimotopic algorithmic approach for biclustering analysis of expression data. It is well known that quantum computers are superior to classical computers in efficiently simulating quantum systems. Here we report the first experimental simulation of quantum tunneling through potential barriers, a widespread phenomenon of a unique quantum nature, via NMR techniques. Our experiment is based on a Experimental simulation of quantum tunneling in small systems of an in silico designed anticancer Peptide SVS-1 multipharmacophore as a potential drug-like efficator in Preceding Membrane Neutralization by CHARMM additive and polarizable force fields for biophysics and computer-aided drug design multi-mimotopic algorithmic approach for biclustering analysis of expression data simulation algorithm and requires very few spin-1/2 nuclei without the need of ancillary qubits.

Keywords

In silico designed;Anticancer Peptide; SVS-1 multipharmacophore; drug-like efficator; Preceding Membrane Neutralization; multi-mimotopic; algorithmic approach; biclustering analysis; expression data; CHARMM additive; polarizable force fields; biophysics; computer-aided drug design; multi-mimotopic; algorithmic approach; biclustering analysis; expression data;

Recent multi-target machine learning predictors assessing Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses

Abstract

Pancreatic cancer is a highly lethal disease and little therapeutic progress has been achieved in the last decades. Vaccination against cancer is currently tested in many clinical trials as a new treatment modality. Micro-RNA155 (mir-155) has been shown to play a role in germinal center formation, T cell inflammation, and regulatory T cell development. In other studies, the role of mir-155 in cytotoxic T cell function has further been evaluated. In previous studies it has been reported that mice lacking mir-155 have impaired CD8(+) T cell responses to infections with lymphocytic choriomeningitis virus and the intracellular bacteria Listeria monocytogenes. These data suggested that mir-155 may be a good target for therapies aimed at modulating immune responses.In pancreatic cancer, few molecularly characterised antigens have so far been available for use in vaccines. However, the catalytic subunit of telomerase, hTERT, expressed in 85–90% of human cancer tissues (Vasef et al, 1999) and an attractive ‘universal’tumour antigen (Autexier, 1999), is also expressed in pancreatic cancer where it has been used diagnostically (Suehara et al, 1998; Uehara et al, 1999). By turning on hTERT and telomerase activity, cancer cells are enabled to maintain functional telomeres at the end of chromosomes, and are prevented from going into senescence. Telomerase is consequently a key enzyme in the process of immortalisation of cancer cells and has a pivotal role in carcinogenesis. A 100-mer MUC1 peptide consisting of the extracellular tandem repeat domain and incomplete Freund’s adjuvant were subcutaneously administered to 6 pancreatic and 3 bile duct cancer patients at weeks 1, 3 and 5 and doses ranging from 300 to 3000 microg. Extensive analyses demonstrate how these algorithms can be part of an iterative combinatorial chemistry procedure to speed up the discovery and the validation of peptide mimotopic novel leads. Moreover, the proposed approach introduce the use of known ligands for our recent multi-target machine learning predictors in Recent multi-target machine learning predictors assessing Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses.

Keywords

Pilot Research; Scientific Project;Assessing; Intra-Metastasis; Administration;Autologous; Tumor Lysate-pulsed;MicroRNA-155 loaded; Dendritic Cells;immunogenic; pre-conditioned; MUC1;telomerase peptide; GV1001mimetic; polytargeted;computer-aided; predicted;chemopharmacophore;CTL responses;

A Study of Quantum Strategies for Newcomb’s Paradox Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses

Abstract

Newcomb’s problem is a game between two players, one of who has an ability to predict the future: let Bob have an ability to predict Alice’s will. Now, Bob prepares two boxes, Box1 and Box2, and Alice can select either Box2 or both boxes. Box1 contains $1. Box2 contains $1,000 only if Alice selects only Box2; otherwise Box2 is empty($0). Which is better for Alice? Since Alice cannot decide which one is better in general, this problem is called Newcomb’s paradox. In this paper, we propose quantum strategies for this paradox by Bob having quantum ability. Many other results including quantum strategies put emphasis on finding out equilibrium points. On the other hand, our results put emphasis on whether a player can predict another player’s will. Then, we show some positive solutions for a Study of Quantum Strategies for Newcomb’s Paradox Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses.

Keywords

Game Theory, Newcomb’s Paradox, Quantum Strategy, Meyer’s Strategy; Quantum Strategies; Newcomb’s Paradox; Intra-Metastasis; MicroRNA-155; trainig data sets; MUC1- LLDILDTAGHEEYSAMRDQ; targeted domains; telomerase; GV1001 peptide; mimetic chemo-pharmacophores; CTL responses;

CHARMM additive and polarizable force fields for biophysics and computer-aided drug design Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses

Abstract

Background

Molecular Mechanics (MM) is the method of choice for computational studies of biomolecular systems owing to its modest computational cost, which makes it possible to routinely perform molecular dynamics (MD) simulations on chemical systems of biophysical and biomedical relevance.

Scope of Review

As one of the main factors limiting the accuracy of MD results is the empirical force field used, the present paper offers a review of recent developments in the CHARMM additive force field, one of the most popular bimolecular force fields. Additionally, we present a detailed discussion of the CHARMM Drude polarizable force field, anticipating a growth in the importance and utilization of polarizable force fields in the near future. Throughout the discussion emphasis is placed on the force fields’ parametrization philosophy and methodology.

General Significance

Addressing the limitations ensures the reliability of the new CHARMM36 additive force field for the types of calculations that are presently coming into routine computational reach while the availability of the Drude polarizable force fields offers a model that is an inherently more accurate model of the underlying physical forces driving macromolecular structures and dynamics.

Major Conclusions

Recent improvements in the CHARMM additive force field are mostly related to newly found weaknesses in the previous generation of additive force fields. Beyond the additive approximation is the newly available CHARMM Drude polarizable force field, which allows for MD simulations of CHARMM additive and polarizable force fields for biophysics and computer-aided drug design Intra-Metastasis MicroRNA-155 trainig data sets on MUC1- LLDILDTAGHEEYSAMRDQ targeted domains by a telomerase GV1001 peptide mimetic chemo-pharmacophores for the future induction of CTL responses.

Keywords

CHARMM additive; polarizable force fields; biophysics; computer-aided drug design; Intra-Metastasis; MicroRNA-155; trainig data sets; MUC1- LLDILDTAGHEEYSAMRDQ; targeted domains; telomerase; GV1001 peptide mimetic; chemo-pharmacophores; CTL responses; molecular dynamics, empirical force field, potential energy function, molecular mechanics, computer-aided drug design, biophysics;